SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SKYEY - SkyePharma PLC -- Ignore unavailable to you. Want to Upgrade?


To: Dr. John M. de Castro who wrote (22)4/28/1999 9:15:00 AM
From: Dr. John M. de Castro  Respond to of 56
 
SKYE and SEPR are jointly developing metered dose inhaler formulations of SEPR's chiral forms of asthma drugs. Recently SEPR announced excellent clinical results for one of those drugs. I do not believe that the metered dose inhaler delivery was used here. But, these are very encouraging results that the drugs covered under the joint agreement are very promising.

biz.yahoo.com

John de C